CI vs. MRK

In the year-to-date period, CI achieves a 22.04% return, which is significantly higher than MRK's -16.11% return. Over the past 10 years, CI has outperformed MRK with an annualized return of 10.65%, while MRK has yielded a comparatively lower 6.99% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CI Sharpe Ratio is -0.12, which is higher than the MRK Sharpe Ratio of -1.27. The chart below compares the historical Sharpe Ratios of CI and MRK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CI's dividend yield for the trailing twelve months is around 1.70%, less than MRK's 3.82% yield.

The maximum CI drawdown since its inception was -84.34%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for CI and MRK. For additional features, visit the drawdowns tool.

The current volatility for Cigna Corporation (CI) is 8.01%, while Merck & Co., Inc. (MRK) has a volatility of 11.66%. This indicates that CI experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Cigna Corporation and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.